Clinical diagnosis of smear-negative pulmonary tuberculosis: an audit of diagnostic practice in hospitals in Malawi.

Int J Tuberc Lung Dis

National Tuberculosis Control Programme, Ministry of Health, Lilongwe, Malawi.

Published: December 2001

Setting: Thirty-seven hospitals in Malawi.

Objective: To audit the hospital practice of clinically diagnosing adults with smear-negative pulmonary tuberculosis (PTB).

Design: A cross-sectional survey of adults aged 15 years or above who were registered and receiving inpatient treatment for smear-negative PTB. An assessment of each patient was carried out to determine 1) the number of recommended diagnostic guidelines (cough >3 weeks, no response to antibiotics, negative sputum smears and a chest radiograph compatible with PTB) used by hospital staff in making the diagnosis of PTB, and 2) whether the clinical diagnosis of smear-negative PTB was correct according to criteria set by the study.

Results: There were 259 patients, 127 men and 132 women, with a mean age of 37 years; 93% had a cough >3 weeks, 95% had received one or more courses of antibiotics, 92% had submitted sputum samples for smear examination and 97% had chest radiographs performed. In 148 (57%) patients, all four diagnostic guidelines were used, and in 238 (92%) patients three or more were used. The diagnosis of smear-negative PTB was considered correct by study criteria in 203 (78%) patients. In the remainder, 22 (8%) were considered to have extrapulmonary TB and 34 (14%) another diagnosis.

Conclusion: Hospital practices in the diagnosis of smear-negative PTB are reasonable, although there is room for improvement with in-service training and regular audits of practice.

Download full-text PDF

Source

Publication Analysis

Top Keywords

diagnosis smear-negative
16
smear-negative ptb
16
clinical diagnosis
8
smear-negative pulmonary
8
pulmonary tuberculosis
8
diagnostic guidelines
8
cough weeks
8
smear-negative
6
ptb
6
tuberculosis audit
4

Similar Publications

This study aimed to evaluate the diagnostic value of rapid simultaneous RNA amplification and testing for tuberculosis (SAT-TB) in smear-negative pulmonary tuberculosis (PTB). We performed a multicenter prospective analysis of 206 patients with smear-negative suspected PTB between December 2018 and March 2022. We collected sputum or bronchoalveolar lavage fluid (BALF) for simultaneous SAT-TB and Xpert Mycobacterium tuberculosis/rifampin (MTB/RIF) assays.

View Article and Find Full Text PDF

Study on the early diagnostic value of nanopore sequencing in alveolar lavage fluid smear-negative pulmonary tuberculosis.

Braz J Microbiol

December 2024

Department of Infectious Diseases, Xiangya Medical College, Zhuzhou Central Hospital (Zhuzhou Hospital, Central South University), Zhuzhou, Hunan, 412007, China.

The objective of this study was to investigate the early diagnostic value of nanopore sequencing in alveolar lavage smear-negative pulmonary tuberculosis (PTB). A prospective study was conducted on patients hospitalized at Zhuzhou Central Hospital from October 2021 to June 2022 and suspected to have PTB. Alveolar lavage fluid specimens were collected from these patients and simultaneously subjected to centrifugal bacterial collection smear method in a sandwich cup, bifidobacteria solid culture (referred to as culture), Mycobacterium tuberculosis-DNA (TB-DNA), and nanopore sequencing for detection of Mycobacterium tuberculosis.

View Article and Find Full Text PDF

Microbiological aspects and clinical impact of lower lung field tuberculosis: An observational cohort study in Peru.

Int J Infect Dis

January 2025

Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA; Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address:

Article Synopsis
  • Approximately 40% of global tuberculosis cases go undiagnosed, with lower lung field TB (LLF TB) frequently misidentified as other lung issues, causing treatment delays.
  • An observational study in Lima, Peru, found that among 1316 pulmonary TB patients, 6% had LLF TB, which tended to be smear-negative, indicating a less typical presentation of the disease.
  • LLF TB patients showed less improvement in their respiratory health after 2 months of treatment, yet they had better final treatment outcomes compared to those with non-LLF TB, highlighting the need for optimized care for this specific group.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the performance of a tuberculosis lab in Hawassa, focusing on the processing of 439 clinical specimens using established methods.
  • Recovery rates for smear-positive samples were significantly higher (over 58%) compared to smear-negative samples (4.5%), indicating challenges in detecting active infections.
  • The findings highlight the need for improvements in recovery rates for smear-negative cultures and controlling contamination, which affected approximately 9.7% of samples.
View Article and Find Full Text PDF

Duplex recombinase aided amplification-lateral flow dipstick assay for rapid distinction of and .

Front Cell Infect Microbiol

October 2024

Department of Medical Microbiology, School of Basic Medicine, Shandong Second Medical University, Weifang, Shandong, China.

Objectives: This study aims to develop a novel diagnostic approach using the recombinase aided amplification-lateral flow dipstick(RAA-LFD) assay for the distinction of (MTB) and (MAC), enabling rapid and convenient as well as accurate identification of them in clinical samples.

Methods: Our study established a duplex RAA-LFD assay capable of discriminating between MTB and MAC. Based on the principles of RAA primer and probe design, specific primers and probes were developed targeting the MTB and the MAC separately.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!